Patents by Inventor Seiji Isonishi

Seiji Isonishi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Taxol and epidermal growth factor used to enhance treatment of ovarian cancer
    Patent number: 5597798
    Abstract: The present invention comprises a method of sensitizing various types of cancer cells derived from different tissues of origin to various cytotoxic agents and augmenting the sensitivity of cancer cells to these cytotoxic agents. The invention provides a method to treat cancer and other cell proliferative diseases by the administration of a sensitizing agent prior to or concurrently with the administration of a cytotoxic agent.
    Type: Grant
    Filed: March 11, 1994
    Date of Patent: January 28, 1997
    Assignee: The Regents of the University of California
    Inventors: Stephen B. Howell, Randolph D. Christen, Seiji Isonishi, Paul A. Andrews
  • Enhancement of anti-neoplastic drug efficacy using EGF
    Patent number: 5252342
    Abstract: The present invention comprises a method of sensitizing cancer cells to cisplatin or other cytotoxic agents and augmenting the sensitivity of cancer cells to these cytotoxic agents. The invention provides a method to treat cancer and other cell proliferative diseases by the administration of a sensitizing agent prior to or concurrently with the administration of a cytotoxic agent.
    Type: Grant
    Filed: March 5, 1990
    Date of Patent: October 12, 1993
    Assignee: The Regents of the University of California
    Inventors: Stephen B. Howell, Randolph D. Christen, Seiji Isonishi, Paul A. Andrews